• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Erasca, Inc. - Common Stock (NQ:ERAS)

12.47 +0.97 (+8.43%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,379,523
Open 11.59
Bid (Size) 12.43 (300)
Ask (Size) 12.55 (2,000)
Prev. Close 11.50
Today's Range 11.59 - 12.87
52wk Range 1.060 - 24.28
Shares Outstanding 151,043,118
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
ERAS INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Erasca, Inc.
May 19, 2026
From Kirby McInerney LLP
Via Business Wire
News headline image
ERASCA INVESTOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Erasca, Inc. on Behalf of Erasca Stockholders and Encourages Investors to Contact the Firm
May 19, 2026
From Bragar Eagel & Squire
Via GlobeNewswire

Performance

YTD
+247.4%
+247.4%
1 Month
-34.9%
-34.9%
3 Month
-8.4%
-8.4%
6 Month
+306.2%
+306.2%
1 Year
+1054.6%
+1054.6%

More News

Read More
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS
May 19, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Biotech Fund Sells $44.5 Million Erasca Stake After Massive 700% Rally ↗
May 18, 2026
Via The Motley Fool
Topics Regulatory Compliance
Erasca (NASDAQ:ERAS) Beats Q1 Estimates on Promising ERAS-0015 Data ↗
May 11, 2026
Via Chartmill
News headline image
Alumis Stock Has Soared 400%. Cormorant Bought Another $8 Million Last Quarter ↗
May 17, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why This Fund Just Made a $55 Million Bet on Dianthus Amid a 350% Stock Rally ↗
May 17, 2026
Via The Motley Fool
News headline image
Erasca Stock Is Up 715%. Here’s Why One Biotech Fund Still Bought $68 Million More ↗
May 17, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Erasca Touts 'Eye-Popping' ERAS-0015 Lung Cancer Data, FDA Path at BofA Conference ↗
May 16, 2026
Via MarketBeat
News headline image
Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy ↗
May 16, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
ERAS SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
May 14, 2026
From Kirby McInerney LLP
Via GlobeNewswire
News headline image
ERASCA INVESTOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Erasca, Inc. on Behalf of Erasca Stockholders and Encourages Investors to Contact the Firm
May 14, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
What to Know About This Fund’s $50 Million Exit From Ascendis Pharma ↗
May 14, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Fund Has a $75 Million Bet on a Hair Loss Biotech Stock Up More Than 500% Post-IPO ↗
May 14, 2026
Via The Motley Fool
Topics Initial Public Offering
News headline image
Why This Hedge Fund Added $29 Million to a Cancer Stock Already Up 700% ↗
May 14, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
ERASCA, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
May 12, 2026
From Kirby McInerney LLP
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Erasca, Inc. - ERAS
May 12, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
ERAS Investors Have Opportunity to Join Erasca, Inc. Fraud Investigation with the Schall Law Firm
May 10, 2026
From Schall Law
Via GlobeNewswire
News headline image
Stock Market Today, April 28: Erasca Plunges After Patient Death in Early Cancer Drug Trial ↗
April 28, 2026
Via The Motley Fool
Topics Stocks
Here are the top movers in Tuesday's session. ↗
April 28, 2026
Via Chartmill
Which stocks are experiencing notable movement on Tuesday? ↗
April 28, 2026
Via Chartmill
Gapping stocks in Tuesday's session ↗
April 28, 2026
Via Chartmill
Top movers in Tuesday's pre-market session ↗
April 28, 2026
Via Chartmill
What's going on in today's after hours session ↗
April 27, 2026
Via Chartmill
News headline image
Erasca CMO's Direct Stake Hit Zero. Her Options Position Didn't ↗
March 26, 2026
Via The Motley Fool
Topics Regulatory Compliance

Frequently Asked Questions

Is Erasca, Inc. - Common Stock publicly traded?
Yes, Erasca, Inc. - Common Stock is publicly traded.
What exchange does Erasca, Inc. - Common Stock trade on?
Erasca, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Erasca, Inc. - Common Stock?
The ticker symbol for Erasca, Inc. - Common Stock is ERAS on the Nasdaq Stock Market
What is the current price of Erasca, Inc. - Common Stock?
The current price of Erasca, Inc. - Common Stock is 12.47
When was Erasca, Inc. - Common Stock last traded?
The last trade of Erasca, Inc. - Common Stock was at 05/27/26 04:00 PM ET
What is the market capitalization of Erasca, Inc. - Common Stock?
The market capitalization of Erasca, Inc. - Common Stock is 1.88B
How many shares of Erasca, Inc. - Common Stock are outstanding?
Erasca, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap